Cargando…
Pharmacological chaperone reshapes the energy landscape for folding and aggregation of the prion protein
The development of small-molecule pharmacological chaperones as therapeutics for protein misfolding diseases has proven challenging, partly because their mechanism of action remains unclear. Here we study Fe-TMPyP, a tetrapyrrole that binds to the prion protein PrP and inhibits misfolding, examining...
Autores principales: | Gupta, Amar Nath, Neupane, Krishna, Rezajooei, Negar, Cortez, Leonardo M., Sim, Valerie L., Woodside, Michael T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931252/ https://www.ncbi.nlm.nih.gov/pubmed/27346148 http://dx.doi.org/10.1038/ncomms12058 |
Ejemplares similares
-
A mathematical model of the dynamics of prion aggregates with chaperone-mediated fragmentation
por: Davis, Jason K., et al.
Publicado: (2015) -
Pharmacological inactivation of the prion protein by targeting a folding intermediate
por: Spagnolli, Giovanni, et al.
Publicado: (2021) -
Reshaping the research landscape in Brazil
por: Crestana, Gustavo Schiavone, et al.
Publicado: (2023) -
Chaperones caught partying with prions
por: Sedwick, Caitlin
Publicado: (2015) -
Single-molecule force spectroscopy of the add adenine riboswitch relates folding to regulatory mechanism
por: Neupane, Krishna, et al.
Publicado: (2011)